Embecta Corp. (EMBC)
(Real Time Quote from BATS)
$15.16 USD
+1.99 (15.11%)
Updated Jul 22, 2024 03:24 PM ET
3-Hold of 5 3
A Value F Growth F Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
EMBC 15.16 +1.99(15.11%)
Will EMBC be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for EMBC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for EMBC
Best Value Stocks to Buy for May 15th
Cencora (COR) Q2 Earnings Top Estimates
EMBC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Best Value Stocks to Buy for February 12th
Embecta Corp. (EMBC) Surpasses Q1 Earnings and Revenue Estimates
Premier, Inc. (PINC) Q2 Earnings Surpass Estimates
Other News for EMBC
Why CrowdStrike Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Embecta (EMBC) Shares Cross Above 200 DMA
IQVIA Posts Upbeat Earnings, Joins Terex, Reddit And Other Big Stocks Moving Higher On Monday
Diabetes device maker Embecta exploring sale - FT
Analysts Conflicted on These Healthcare Names: Healthequity (HQY) and Embecta Corporation (EMBC)